Learn about NCI SBIR/STTR Phase IIB Bridge Award and hear from awardees who have successfully received the award!
The goal of NCI SBIR PLAN Webinar Series is to help SBIR- and STTR-funded companies learn from peers and facilitate collaboration amongst awardeed companies. This PLAN Webinar will focus on the NCI SBIR/STTR Phase IIB Bridge Award, a post-Phase-II funding for any SBIR/STTR funded cancer technology projects. Three previous Bridge Awardees will be on the webinar as panelists and share their experiences and insights going from Phase II to Phase IIB Bridge, including preparing the application and finding investors for the required matching fund.
The main webinar will be followed by 3 breakout sessions--each panelist will be available for a 30-minute free-form discussion on Bridge Award, as well as potential areas of collaboration. The breakout session will be a great place to get to know other SBIR awardees and discuss potential areas of collaboration with one another.
Moderator: Tood Haim, Program Director, NCI SBIR Development Center
Chuck Scheper, Chairman of the Board, Bexion Pharmaceuticals
Nilabh Chaudhary, Science Advisor, Bexion Pharmaceuticals
Michael Cardone, President & CEO, Eutropics Pharmaceuticals
Greg King, President & CEO, Fibralign Corporation
2:00 – 2:05 PM Introduction
2:05 – 2:15 PM Bridge Award 101 by Todd Haim
2:15 – 2:45 PM Panelist Session
2:45 – 3:00 PM Q&A
3:00 – 3:30 PM Breakout session with each panelist